FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway
Authors:
Open Access
- 4 December 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (10) , 8870-8886
Abstract
FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathwayKeywords
This publication has 58 references indexed in Scilit:
- Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemiaNature, 2012
- Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors: Figure 1.Genes & Development, 2012
- A potential therapeutic target for FLT3-ITD AML: PIM1 kinaseLeukemia Research, 2012
- c-Cbl and Cbl-b Ligases Mediate 17-Allylaminodemethoxygeldanamycin-induced Degradation of Autophosphorylated Flt3 Kinase with Internal Tandem Duplication through the Ubiquitin Proteasome PathwayJournal of Biological Chemistry, 2011
- The Pim protein kinases regulate energy metabolism and cell growthProceedings of the National Academy of Sciences, 2010
- Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4ECancer Cell, 2010
- Structural and Functional Alterations of FLT3 in Acute Myeloid LeukemiaClinical Cancer Research, 2009
- mTORC1 promotes survival through translational control of Mcl-1Proceedings of the National Academy of Sciences, 2008
- Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cellsProceedings of the National Academy of Sciences, 2007
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005